MIF and colorectal carcinoma: Interestingly, we confirmed that MIF blocking by 4-IPP also inhibits cell viability on two previously described cetuximab-resistant CRC cell lines [15,16,30]: LIM1215-CR (Figure S4A) and SW48-CR (Figure S4B).